Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Management of Atrial Flutter with Controlled Rate and Respiratory Distress

Initial Assessment and Management

  • For a patient with atrial flutter, controlled rate, and respiratory distress, immediate synchronized cardioversion is recommended as the first-line treatment to restore sinus rhythm and improve respiratory status, according to the American Heart Association 1, 2
  • Evaluate hemodynamic stability, as the presence of respiratory distress suggests clinical instability that warrants immediate intervention, as recommended by the American College of Cardiology 3, 4
  • Check anticoagulation status, considering the risks vs. benefits of immediate cardioversion if the patient has been in atrial flutter for ≥48 hours and is not adequately anticoagulated, as suggested by the American Heart Association 3, 5

Cardioversion Procedure

  • Perform synchronized electrical cardioversion starting at lower energy settings (50-100J) as atrial flutter often responds to lower energy than atrial fibrillation, according to the American College of Cardiology 1, 2
  • If initial cardioversion is unsuccessful, increase energy in stepwise fashion, as recommended by the American Heart Association 1

Alternative Options if Cardioversion is Delayed or Contraindicated

  • IV beta blockers (esmolol preferred due to rapid onset) or calcium channel blockers (diltiazem) can be used for temporary rate control if cardioversion must be delayed, as suggested by the American College of Cardiology 4, 2
  • For patients with systolic heart failure where beta blockers are contraindicated or ineffective, IV amiodarone can be used for acute rate control, according to the American Heart Association 5, 4

Anticoagulation Considerations

  • Antithrombotic therapy should follow the same guidelines as for atrial fibrillation, as recommended by the American College of Cardiology 3, 5
  • If atrial flutter duration is ≥48 hours or unknown, anticoagulation should be initiated before cardioversion if possible, according to the American Heart Association 3

Long-term Management After Acute Episode

  • Catheter ablation of the cavotricuspid isthmus (CTI) is the preferred definitive treatment for recurrent symptomatic atrial flutter, as recommended by the American College of Cardiology 3, 1
  • Beta blockers, diltiazem, or verapamil are useful for long-term rate control if rhythm control is not pursued, according to the American Heart Association 5, 4

Important Clinical Considerations

  • Rate control can be more difficult to achieve in atrial flutter than in atrial fibrillation due to less concealed AV nodal conduction, as suggested by the American College of Cardiology 5, 4
  • Atrial flutter and atrial fibrillation frequently coexist—22-50% of patients develop atrial fibrillation within 14-30 months after CTI ablation, according to the American Heart Association 4, 2
  • The underlying cause of respiratory distress should be investigated and treated (e.g., heart failure exacerbation, pneumonia), as recommended by the American College of Cardiology 4